Kirtland Hills Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Buy
425
+27
+7% +$27.6K 0.15% 124
2026
Q1
$366K Buy
398
+55
+16% +$55.8K 0.12% 132
2025
Q4
$369K Hold
343
0.13% 126
2025
Q3
$262K Buy
343
+16
+5% +$11.9K 0.1% 142
2025
Q2
$255K Hold
327
0.12% 135
2025
Q1
$274K Buy
327
+21
+7% +$17.5K 0.17% 124
2024
Q4
$237K Buy
306
+62
+25% +$51.3K 0.15% 121
2024
Q3
$217K Buy
+244
New +$219K 0.12% 130

Other funds holding LLY

Kirtland Hills Capital Management's LLY Position: Q2 2026 in Review

Kirtland Hills Capital Management increased its Eli Lilly (LLY) stake by 6.8% in Q2 2026, buying an estimated $27.6K and bringing the position to 425 shares worth $510K. The position accounts for 0.15% of the portfolio, ranked #124.

Kirtland Hills Capital Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kirtland Hills Capital Management held 425 shares of Eli Lilly worth $510K as of Q2 2026.
  • Kirtland Hills Capital Management bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.15% of Kirtland Hills Capital Management's portfolio in Q2 2026, its #124 holding.
  • Kirtland Hills Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.